Targeted Nanoparticles for Imaging Incipient Pancreatic Ductal Adenocarcinoma

Abstract

Our approach exploited a well-defined model of PDAC, enabling rapid identification and validation of PTP. The developed specific imaging probe, along with the discovery of plectin-1 as a novel biomarker, may have clinical utility in the diagnosis and management of PDAC in humans.